{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:41Z","timestamp":1793109701717,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.leukres.2006.08.001","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T08:34:42Z","timestamp":1159432482000},"page":"673-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells"],"prefix":"10.1016","volume":"31","author":[{"given":"Takayuki","family":"Ikezoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Bandobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokuni","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.08.001_bib1","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.08.001_bib2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.08.001_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support","volume":"12","author":"Taguchi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.leukres.2006.08.001_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.08.001_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","article-title":"PI3K: downstream AKTion blocks apoptosis","volume":"88","author":"Franke","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2006.08.001_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccr.2004.05.027","article-title":"Lost in translation: dysregulation of cap-dependent translation and cancer","volume":"5","author":"Bjornsti","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2006.08.001_bib7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2006.08.001_bib8","first-page":"1904","article-title":"Adenoviral-mediated expression of MMAC\/PTEN inhibits proliferation and metastasis of human prostate cancer cells","volume":"8","author":"Davies","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2006.08.001_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2006.08.001_bib10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2006.08.001_bib11","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1073\/pnas.95.26.15587","article-title":"The PTEN\/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase\/Akt pathway","volume":"95","author":"Wu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.08.001_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190400007565","article-title":"The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia","volume":"4","author":"Larizza","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.08.001_bib13","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1038\/sj.onc.1209088","article-title":"The Akt\/PKB pathway: molecular target for cancer drug discovery","volume":"24","author":"Cheng","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2006.08.001_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/emboj\/17.3.743","article-title":"Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase","volume":"17","author":"Jimenez","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2006.08.001_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1349-7006.2004.tb02215.x","article-title":"Proteasome inhibitor PS-341 down-regulates level of PSA and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells","volume":"95","author":"Ikezoe","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2006.08.001_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/1535-7163.MCT-04-0277","article-title":"Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways","volume":"4","author":"Ikezoe","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2006.08.001_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/1535-7163.473.3.4","article-title":"HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1\/2","volume":"3","author":"Ikezoe","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"10.1016\/j.leukres.2006.08.001_bib18","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/sj.onc.1204364","article-title":"Phosphoinositide-3 kinase-PKB\/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax","volume":"3","author":"Liu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2006.08.001_bib19","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1038\/sj.onc.1208825","article-title":"Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells","volume":"24","author":"Jeong","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2006.08.001_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2404129","article-title":"Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor","volume":"20","author":"Sanda","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.08.001_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2006.08.001_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/BJ20041888","article-title":"Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)","volume":"388","author":"Rolfe","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.leukres.2006.08.001_bib23","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2004-06-2494","article-title":"Antileukemic activity of rapamycin in acute myeloid leukemia","volume":"105","author":"Recher","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.08.001_bib24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.08.001_bib25","series-title":"Proceedings of the ASCO annual meeting","article-title":"A phase I study with tumor molecular pharmacodynamic evaluation of dose and schedule of the oral mTOR-inhibitor Everolimus (RAD001) in patients with advanced solid tumors","author":"Tabernero","year":"2005"},{"key":"10.1016\/j.leukres.2006.08.001_bib26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.08.001_bib27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.bjp.0706061","article-title":"LY294002 and rapamycin co-operate to inhibit T-cell proliferation","volume":"144","author":"Breslin","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.leukres.2006.08.001_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.leukres.2006.08.001_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor\u2013mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:55:53Z","timestamp":1758934553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606003043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0145212606003043"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.08.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2006.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}